Skip to main content

Results, Reports and Publications

Latest Results

Clariant delivers strong underlying margin improvement in the second quarter and increases 2024 profitability outlook to ~ 16 % EBITDA margin

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

  • Q2 2024 sales decreased by 3 % organically in local currencies1 to CHF 1.056 billion as growth in Care Chemicals and Adsorbents & Additives was offset by an expected decline in Catalysts
  • Q2 2024 reported EBITDA margin decreased to 15.7 % compared to 16.1 % in Q2 2023, underlying improvement excluding prior year’s disposal gain of more than 500 basis points driven by positive operating leverage and reduced sunliquid® impact
  • H1 2024 sales decreased by 5 % organically in local currencies1 to CHF 2.070 billion
  • H1 2024 reported EBITDA margin improved to 16.4 % compared to 15.0 % in prior year
  • H1 2024 Operating Cash Flow at CHF 112 million, compared to CHF 78 million in H1 2023; strong Free Cash Flow Conversion (LTM) of 42 %
  • Outlook 2024: Flat to low single-digit percent sales growth in local currency, increase in expected reported EBITDA margin by 100 basis points to around 16.0 %, medium-term targets confirmed

"Clariant delivered a strong underlying margin improvement in the second quarter of 2024 toward 16 %. This progress results from successfully implementing our leaner, customer-focused operating model and continued execution of our performance improvement programs. As a result, we benefitted from improved operating leverage as we achieved growth in our Care Chemical and Adsorbents & Additives businesses while maintaining pricing discipline. We are pleased with the improved cash generation in the first half of 2024 and the progress in our strategic initiatives. The integration of Lucas Meyer Cosmetics is well on track. In addition, our sale of the Podari plant assets and disciplined execution of the downsizing of the bioethanol business will lead to a CHF 20 million lower financial impact than originally expected. Due to this improvement, together with the strong operational performance in the first six months of 2024, we have increased our profitability guidance by 100 basis points for the full year although we expect no signs of a broad market recovery in the second half of the year. 2024 will be a meaningful step towards our medium-term targets." said Conrad Keijzer, Chief Executive Officer of Clariant.

1 All references to local currency growth, pricing, volumes, and scope exclude the impact from hyperinflation countries Argentina and Türkiye. All references to currency include a net impact from hyperinflation countries Argentina and Türkiye.

Read more  

Upcoming Results

On  29 October 2024, Clariant will present its Third Quarter / Nine Month Figures 2024.

The results will be published at 7.00 AM CET and a conference call and webcast for analysts and investors will start at 3.00 PM CET. 

Conference call participants are kindly requested to register here.

Results Center

Please use the Results Center to find Clariant’s financial results and associated documents as published in the last five years

  Q1  Q2  Q3  Q4 
Date  30 April 2024 30 July 2024 29 October 2024  28 February 2025
Quiet Period as of  11 April as of 10 July   as of 9 October    
Media Release  EN  EN    
Analyst Presentation EN  EN    
Webcast   Replay  Link  
Audio recording MP3 MP3    
Transcript  EN EN    
Financial Review / HY Report   EN - XLS    
Annual Report        

  Q1  Q2  Q3  Q4 
Date  5 May 2023  28 July 2023  30 October 2023  29 February 2024 
Quiet Period as of  17 April as of 10 July as of 10 October as of 15 January 
Media Release  EN — DE  EN — DE EN — DE  EN — DE
Analyst Presentation  EN  EN EN  EN
Webcast        
Audio recording MP3  MP3  MP3  MP3
Transcript  EN  EN EN EN 
Financial Review / HY Report   EN   EN — XLS
Annual Report       EN 

  Q1  Q2  Q3  Q4 
Date  15 June 2022  28 July 2022  27 October 2022  2 March 2023 
Quiet Period   as of 11 July  as of 10 October  as of 17 February 
Media Release  EN — DE EN — DE  EN — DE  EN — DE 
Analyst Presentation  EN  EN  EN  EN 
Webcast        
Audio recording MP3  MP3  MP3  MP3 
Transcript 
    EN 
Financial Review / HY Report   EN    EN 
Annual Report       EN 

  Q1  Q2  Q3  Q4 
Date  29 April 2021  29 July 2021  28 October 2021  19 May 2022 
Quiet Period as of 19 April  as of 12 July  as of 18 October   
Media Release  EN — DE EN — DE  EN — DE  EN — DE 
Analyst Presentation  EN  EN  EN  EN 
Webcast        
Audio recording MP3  MP3  MP3  MP3 
Transcript       
Financial Review / HY Report   EN    EN 
Annual Report        EN  

  Q1  Q2  Q3  Q4 
Date  30 April 2020  30 July 2020  29 October 2020  11 February 2021 
Quiet Period        
Media Release  EN — DE  EN — DE  EN — DE  EN — DE 
Analyst Presentation  EN  EN  EN  EN 
Webcast        
Audio recording MP3  MP3  MP3  MP3 
Transcript         
Financial Review / HY Report   EN    EN 
Annual Report        EN  

  Q1  Q2  Q3  Q4 
Date  30 April 2019  25 July 2019  30 October 2019  13 February 2020 
Quiet Period        
Media Release  EN — DE  EN — DE   EN — DE   EN — DE  
Analyst Presentation  EN  EN  EN  EN 
Webcast        
Audio recording MP3  MP3  MP3  MP3 
Transcript         
Financial Review / HY Report   EN    EN 
Annual Report        EN 

Conferences and Roadshows

Clariant's Management and Investor Relations Team regularly participates in Conferences and Roadshows. Below you can find an overview of the presentations provided at such events in the last two years. 

For an overview of upcoming events, please refer to the Financial Calendar.

Page summary

Summarization in progress